biomedicina slovenica

"Fluorouracil" : 127

  1. Petit Claire; Lacas Benjamin; Pignon Jean-Pierre; Le Quynh-Thu; Grégoire Vincent; Grau Cai; Hackshaw Allan; Zackrisson Björn; Parmar Mahesh K. B.; Blanchard Pierre; Strojan Primož; Zakotnik Branko
    Chemotherapy and radiotherapy in locally advanced head and neck cancer
    2021 ►
  2. Madorran Eneko; Stožer Andraž; Arsov Zoran; Maver Uroš; Rožanc Jan
    A promising method for the determination of cell viability: the membrane potential cell viability assay
    2022 ►
  3. Zupančič Tina; Zakotnik Branko; Grašič-Kuhar Cvetka
    Outcome of patients with recurrent/metastatic squamous cell head and neck cancer treated with platinum-based chemotherapy with or without cetuximab in real-world practice
    2021 ►
  4. Veitch Zachary; Khan Omar F.; Tilley Derek; Tang Patricia; Ribnikar Domen; Stewart Douglas A.; Kostaras Xanthoula; King Karen; Lupichuk Sasha
    Impact of cumulative chemotherapy dose on survival with adjuvant FEC-D chemotherapy for breast cancer
    2019 ►
  5. Veitch Zachary; Khan Omar F.; Tilley Derek; Ribnikar Domen; Kostaras Xanthoula; King Karen; Tang Patricia; Lupichuk Sasha
    Real-world outcomes of adjuvant chemotherapy for node-negative and node-positive HER2-positive breast cancer
    2019 ►
  6. Tuta Mojca; Boc Nina; Brecelj Erik; Peternel Monika; Velenik Vaneja
    Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure
    2021 ►
  7. Bahadoer Renu R.; Dijkstra Esmée A.; Etten Boudewijn van; Marijnen Corrie A. M.; Putter Hein; Roodvoets Annet G. H.; Nagtegaal Iris; Blomqvist Lennart K.; Edhemović Ibrahim
    Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO)
    2021 ►
  8. Anderluh Franc; Toplak Miha; Velenik Vaneja; Oblak Irena; Šečerov Ermenc Ajra; Jeromen Ana; But-Hadžić Jasna; Skoblar Vidmar Marija
    Definitive radiochemotherapy in esophageal cancer - a single institution experience
    2019 ►
  9. Grašič-Kuhar Cvetka; Strojan Primož; Zadnik Vesna; Zakotnik Branko
    Importance of magnesium sulfate supplementation in the prevention of hypomagnesemia and hypocalcemia during chemoradiation in head and neck cancer
    2018 ►
  10. Saba Nabil F.; Mody Mayur D.; Tan Elaine S.; Gill Harpaul S.; Rinaldo Alessandra; Takes Robert P.; Strojan Primož; Hartl Dana M.; Vermorken Jan B.; Haigentz Missak; Ferlito Alfio
    Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN)
    2017 ►
  11. Bonnefoi Herve; Jacot W.; Saghatchian M.; Moldovan C.; Venat-Bouvet L.; Zaman Khurshid; Matos Erika; Petit T.; Bodmer A.; Quenel-Tueux N.; Chakiba C.
    Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer
    2015 ►
  12. Rades Dirk; Strojan Primož; Seidl Daniel; Janssen Stefan; Bajrovic Amira; Kazic Nadja; Hakim Samer G.; Wollenberg Barbara; Schild Steven E.
    Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck
    2016 ►
  13. Seidl Daniel; Janssen Stefan; Strojan Primož; Bajrovic Amira; Schild Steven E.; Rades Dirk
    Prognostic factors after definitive radio(chemo)therapy of locally advanced head and neck cancer
    2016 ►
  14. Seidl Daniel; Janssen Stefan; Strojan Primož; Hakim Samer G.; Wollenberg Barbara; Schild Steven E.; Rades Dirk
    Importance of chemotherapy and radiation dose after microscopically incomplete resection of stage III/IV head and neck cancer
    2016 ►
  15. Velenik Vaneja; Anderluh Franc; Oblak Irena; Šegedin Barbara; Zakotnik Branko; Strojan Primož
    Preoperative chemoradiation with concurrent capecitabine for locally advanced resectable rectal cance[r] (LARC)
    2008 ►
  16. Oblak Irena; Češnjevar Monika; Anžič Mitja; But Hadžić Jasna; Šečerov Ermenc Ajra; Anderluh Franc; Velenik Vaneja; Jeromen Ana; Korošec Peter
    The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin
    2016 ►
  17. Ocvirk Janja
    Sistemsko zdravljenje raka debelega črevesa in danke
    [Sistemic treatment of colorectal cancer]
    2009 ►
  18. Ocvirk Janja; Reberšek Martina; Škof Erik
    Randomised prospective phase II study of combination chemotherapy epidoxorubicin, cisplatin, 5-FU (ECF) versus epidoxorubicin, cisplatin, capecitabin (ECX) in patients with advanced or metastatic gastric cancer
    2007 ►
  19. Ocvirk Janja; Reberšek Martina; Škof Erik
    Randomised prospective phase II study of combination chemotherapy epidoxorubicin, cisplatin, 5-FU (ECF) versus epidoxorubicin, cisplatin, capecitabin (ECX) in patients with advanced or metastatic gastric cancer
    2007 ►
  20. Slanc Janika; Čufer Tanja; Kozjek Franc; Sonc Monika
    Preliminary study investigating short-term treatment related quality of life in cisplatin and 5-fluorouracil versus etoposide as salvage therapy in metastatic breast cancer patients
    2003 ►
  21. Bossi Paolo; Saba Nabil F.; Vermorken Jan B.; Strojan Primož; Pala Laura; De Bree Remco; Rodrigo Juan Pablo; López Fernando; Hanna Ehab Y.; Haigentz Missak; Takes Robert P.; Slootweg Pieter Johannes; Silver Carl E.; Silver Carl E.; Rinaldo Alessandra; Ferlito Alfio
    The role of systemic therapy in the management of sinonasal cancer
    2015 ►
  22. Ratoša Ivica; Oblak Irena; Anderluh Franc; Velenik Vaneja; But Hadžić Jasna; Šečerov Ermenc Ajra; Jeromen Ana
    Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
    2015 ►
  23. Kovács Róbert; Csenki Zsolt; Bakos Katalin; Urbányi Béla; Horvath Akos; Garaj-Vrhovac Vera; Gajski Goran; Gerić Marko; Negreira Noelia; Lopez de Alda Miren; Barceló Damià; Heath Ester; Kosjek Tina; Žegura Bojana; Novak Matjaž; Zajc Irena; Baebler Špela; Rotter Ana; Ramšak Živa; Filipič Metka
    Genotoxic effect of 5-fluorouracil in zebrafish after chronic exposure to low doses in a two-generation study
    2014 ►
  24. Čufer Tanja
    Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality
    2014 ►
  25. Strojan Primož; Grašič-Kuhar Cvetka; Žumer Barbara; Kadivec Maksimiljan; Karner Katarina Barbara; Fajdiga Igor; Jančar Boris; Gale Nina; Poljak Mario; Kocjan Boštjan; Zakotnik Branko
    TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck
    2014 ►
  26. Grašič-Kuhar Cvetka; Unk Mojca; Strojnik Ksenija; Zakotnik Branko; Fajdiga Igor; Strojan Primož
    Indukcijska kemoterapija z docetakselom, cisplatinom in 5-fluorouracilom pred kemoradioterapijo pri lokalno napredovalih/neoperabilnih karcinomih glave in vratu - izkušnje Onkološkega inštituta Ljubljana
    [Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil before chemotherapy in locally advanced/inoperable head and neck carcinomas - experiences of Institute of Oncology, Ljubljana]
    2012 ►
  27. Ocvirk Janja; Reberšek Martina; Škof Erik; Hlebanja Zvezdana; Boc Marko
    Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer
    2012 ►
  28. Harbeck Nadia; Čufer Tanja; Borštnar Simona
    Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
    2013 ►
  29. Ocvirk Janja
    Napredek zdravljenja bolnikov z razsejanim rakom debelega črevesa in danke z vidika internista onkologa
    2013 ►
  30. Grašič-Kuhar Cvetka; Zakotnik Branko
    Weekly docetaxel, cisplatin, and 5-fluorouracil as a palliative chemotherapy for patients with relapsed or metastatic head and neck cancer in poor performance status
    2012 ►
  31. Grašič-Kuhar Cvetka
    Zdravljenje ponovljene ali metastatske bolezni s tedensko kemoterapijo docetaxel/cisplatin/5-fluorouracil (TCF) pri bolnikih s ploščatoceličnim rakom glave in vratu
    2012 ►
  32. Grašič-Kuhar Cvetka; Vogrin Andrej; Zakotnik Branko
    Zdravljenje ponovljene ali metastatske bolezni s tedensko kemoterapijo docetaxel/cisplatin/5-fluorouracil (TCF) pri bolnikih s ploščatoceličnim rakom glave in vratu
    2011 ►
  33. Oblak Irena; Petrič Primož; Anderluh Franc; Velenik Vaneja; Fras Albert-Peter
    Long term outcome after combined modality treatment for anal cancer
    [Dolgoročni rezultati kombiniranega zdravljenja raka analnega kanala]
    2012 ►
  34. Bonnefoi Herve; Piccart Martine; Bogaerts Jan; Čufer Tanja
    TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial
    2011 ►
  35. Gruber G; Cole BF; Castiglione-Gertsch M; Holmberg SB; Lindtner J; Golouh R; Collins J; Crivellari D; Thurlimann B; Simoncini E; Fey MF; Gelber RD; Coates AS; Price KN; Goldhirsch A; Viale G; Gusterson BA; Eržen D; Čufer T; Majdič E; Štabuc B; Lamovec J; Jančar J; Vrhovec I; Kramberger M; Novak J; Naglas M; Senčar M; Červek J; Šebek S; Cerar O; Plesničar A; Zakotnik B
    Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
    2008 ►
  36. von Minckwitz Gunter; du Bois Andreas; Schmidt Marcus; Maass Nicolai; Čufer Tanja; de Jongh Felix E; Maartense Eduard; Zielinski Christoph; Kaufmann Manfred; Bauer Wolfgang
    Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study
    2009 ►
  37. Piškur Jure; Kolbak Dorthe; Sondergaard Leif; Pedersen Mogens B
    The dominant mutation Suppressor of black indicates that de novo pyrimidine biosynthesis is involved in the Drosophila tan pigmentation pathway
    1993 ►
  38. Piškur Jure; Sondergaard Leif; Gojković Zoran; Stokbro Birgitte; Hjulsager CHarlotte; Davidson Jeffrey; DeMoll Edward; Rawls John; Bahn Erik
    Observed resistance to pyrimidine analogs and sensitivity to uracil in Drosophila is attributed to deregulation of pyrimidine metabolism
    1994 ►
  39. Andersen G; Merico A; Bjornberg O; Andersen B; Schnackerz KD; Dobritzsch D; Piškur J; Compagno C
    Catabolism of pyrimidines in yeast: a tool to understand degradation of anticancer drugs
    2006 ►
  40. Lundgren Stina; Andersen Birgit; Piškur Jure; Dobritzsch Doreen
    Crystallization and preliminary X-ray data analysis of beta-alanine synthase from Drosophila melanogaster
    2007 ►
  41. Viale Giuseppe; Golouh Rastko
    Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
    2008 ►
  42. Velenik Vaneja
    Kapecitabin kot senzibilizator pri predoperativnem obsevanju bolnikov z lokalno napredovalim resektabilnim rakom danke
    2007 ►
  43. Bohanec-Grabar Petra; Dolžan Vita; Rodriguez-Antona Cristina
    Role of pharmacogenetics for the improvement of cancer tratment
    [Vloga farmakogenetike pri učinkovitejšem zdravljenju raka]
    2007 ►
  44. Pinn Melva E; Austin Laura M; Schomas David A; Miller Robert C
    Case report from Mayo clinic: locally advanced Bartholin gland carcinoma
    [Prikaz primera z Mayo clinic: lokalno napredovali karcinom Bartholinijeve žleze]
    2007 ►
  45. Ocvirk Janja; Reberšek Martina; Velenik Vaneja
    Onkološko zdravljenje bolnikov z rakom debelega črevesa in danke
    [Onkology treatment for patients with colon and rectal cancer]
    2007 ►
  46. Miolo GianMaria; La Mura Nicoletta; Nigri Paola; Murrone Antonio; Da Ronch Laura; Viel Elda; Veronesi Andrea; Lestuzzi Chiara
    The cardiotoxicity of chemotherapy: new prospects for an old problem
    [Kardiotoksičnost kemoterapije. Nove rešitve starega problema]
    2006 ►
  47. Ocvirk Janja
    Zdravljenje bolnikov z rakom debelega črevesa
    [Treatment for patients with colon cancer]
    2006 ►
  48. Gruber Guenther; Bonetti Marco; Nasi Laura M; Price Karen; Castiglione-Gertsch Monica; Rudenstam Carl-Magnus; Holmberg Stig B; Lindtner Jurij; Golouh Rastko; Collins John
    Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from international breast cancer study group trial VI
    2005 ►
  49. Twelves Chris; Wong Alfred; Nowacki Marek P; Abt Markus; Burris Howard; Carrato Alfredo; Cassidy Jim; Cervantes Andres; Fagerberg Jan; Štabuc Borut
    Capecitabine as adjuvant treatment for stage III colon cancer
    2005 ►
  50. Ravnik-Glavač Metka; Berginc Gašper; Potočnik Uroš; Golouh Rastko; Repše Stanislav; Glavač Damjan
    Methodology for molecular genetic screening of microsatellite unstable colorectal cancer and Lynch syndrome
    [Metodologija za molekularnogenetsko presejanje mikrosatelitno nestabilnega kolorektalnega karcinoma in sindroma Lynch]
    2005 ►
  51. Globočnik-Petrovič Mojca; Preskar Andrejka
    Proliferativna vitreoretinopatija
    [Proliferative vitreoretinopathy]
    2005 ►
  52. Ocvirk Janja
    Nov pristop k zdravljenju raka: rak debelega črevesa in danke - pogostnost v svetu in pri nas
    2005 ►
  53. Efficace Fabio; Therasse Patrick; Piccart Martine J; Coens Corneel; van Steen Kristel; Welnicka-Jaskiewicz Marzena; Čufer Tanja; Dyczka Jaroslaw; Lichinitser Michail; Shepherd Lois
    Health-related quality of life parameters as prognostic factors in a nonmestatic breast cancer population: an international multicenter study
    2004 ►
  54. Bohanec Petra; Dolžan Vita
    Genetski polimorfizmi encimov v presnovni poti folata v zdravi slovenski populaciji
    [Genetic polimorphisms of enzymes involved in folate metabolism in healthy Slovenian population]
    2004 ►
  55. Ocvirk Janja
    Sistemsko zdravljenje inoperabilnih jetrnih zasevkov raka debelega črevesa in danke
    2004 ►
  56. Velenik Vaneja; Oblak Irena; Anderluh Franc
    Paliativno zdravljenje raka danke
    2004 ►
  57. Štabuc Borut
    Systemic treatment of colon cancer
    2004 ►
  58. Rogl-Butina Mirjam; Bartenjev Igor
    Nekirurško zdravljenje prekanceroz
    2004 ►
  59. Stojanovič Larisa; Mlakar Boštjan
    Sodobni načini zdravljenja anogenitalnih bradavic
    [Current therapy for anogenital warts]
    2004 ►
  60. Štabuc Borut
    Systemic therapy for colorectal cancer
    2003 ►
  61. Scheithauer W; McKendrick J; Begbie S; Borner M; Burns WI; Burris HA; Cassidy J; Jodrell D; Koralewski P; Štabuc B
    Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial
    2003 ►
  62. Goldhirsch A; Lindtner J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial
    2003 ►
  63. Aebi S; Gelber S; Castiglione-Gertsch M; Gelber RD; Collins J; Thurlimann B; Rudenstam CM; Lindtner J
    Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
    2000 ►
  64. Colleoni M; Litman HJ; Castiglione-Gertsch M; Sauerbrei W; Gelber RD; Bonetti M; Coates AS; Schumacher M; Bastert G; Lindtner J
    Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
    2002 ►
  65. Spataro Vito J; Litman Heather; Viale Giuseppe; Maffini Fausto; Masullo Michele; Golouh Rastko; Lindtner Jurij
    Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from international breast cancer study group trial V
    2003 ►
  66. Ocvirk Janja
    Rak žolčnika in žolčevodov - kemoterapija
    [Cancers of gallbladder and biliary tree - chemotherapy]
    2003 ►
  67. Štabuc Borut
    Uracil/tegafur plus oral leucovorin does not affect survival rates but may be better tolerated than standard fluorouracil and leucovorin for previously untreated metastatic colorectal cancer [comment]
    2003 ►
  68. Štabuc Borut
    Recent advances in the systemic therapy of colorectal cancer
    2003 ►
  69. Therasse P; Mauriac L; Welnicka-Jaskiewicz M; Bruning P; Čufer T; Bonnefoi H; Tomiak E; Pritchard KI; Hamilton A; Piccart MJ
    Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study
    2003 ►
  70. Bonnefoi H; Biganzoli L; Mauriac L; Čufer T; Schaefer P; Atalay G; Piccart M
    An EORTC phase I study of capecitabine (xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer
    2003 ►
  71. Štabuc Borut
    Sistemsko zdravljenje raka trebušne slinavke
    [Chemotherapy for pancreatic cancer]
    2002 ►
  72. Awada A; Biganzoli L; Čufer T; Beex L; Lohrisch C; Batter V; Hamilton A; Nooij M; Piccart M
    An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes
    2002 ►
  73. International breast cancer study group J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial
    2002 ►
  74. Colleoni Marco; Gelber Shari; Coates Alan S; Castiglione-Gertsch Monica; Gelber Richard D; Price Karen; Rudenstam Carl-Magnus; Lindtner Jurij; Collins John; Thuerlimann Beat
    Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
    2001 ►
  75. Bonnefoi H; Biganzoli L; Čufer T; Mauriac L; Hamilton A; Schaefer P; Picart M
    An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer
    2001 ►
  76. Zielinski C; Beslija S; Červek J; Mrsič-Krmpotič Z; Tchernozemsky I; Witschke C; Ghilezan N; Grgič M; Jassem J; Tzekova V
    Gemcitabine/Epirubicin/Paclitaxel (GET) vs. 5-Fluorouracil/Epirubicin/Cyclophosphamide (FEC) as first-line treatment in metastatic breast cancer: interim toxicity analysis of a randomised, multicenter phase III trial of the central European cooperative oncology group (CECOG)
    2001 ►
  77. Awada A; Nooij M; Biganzoli L; Čufer T; Beek L; Batter V; Piccart MJ
    A phase I study of continuous infusion 5-fluorouracil (F-intu) in combination with gemcitabine (GEM) in patients (pts) with anthracycline- (A) refractory or A- and taxane- (T) pretreated metastatic breast cancer (MBC)
    2000 ►
  78. Colleoni Marco; Smith Heather; Castiglione-Gertsch Monica; Gelber Richard D; Sauerbrei Willi; Coates Alan S; Schumacher Martin; Bonetti Marco; Bastert Gunter; Lindtner Jurij
    Duration of adjuvant chemotherapy: a joint analysis of two randomized trails investigating 3 versus 6 courses of cyclophosphamide methotrexate and 5-fluorouracil (CMF) without endocrine treatment
    2000 ►
  79. Crivellari Diana; Eržen D; Cerar O; Štabuc B; Golouh R; Lamovec J; Sebek S; Kramberger M; Vrhovec I
    Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
    2000 ►
  80. Crivellari Diana; Bonetti Marco; Castiglione-Gertsch Monica; Gelber Richard D; Rudenstam Carl-Magnus; Thuerlimann Beat; Price Karen N; Coates Alan S; Huerny Christoph; Lindtner Jurij
    Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International breast cancer study group Trial VII
    2000 ►
  81. Kuhelj Janez
    Prve izkušnje pri zdravljenju kožnih karcinomov z lokalno aplikacijo 5% 5-fluorouracil mazila
    1972 ►
  82. Kolarić K; Potrebica V; Roth A; Stanovnik M
    Controlles phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil vs. 5-fluorouracil alone in gastric and rectosigmoid cancer
    1985 ►
  83. Kolarić K; Potrebica V; Stanovnik M
    Controlled phase III clinical study of 4-epidoxorubicin + 5-fluorouracil versus 5-fluoruracil alone in metastatic gastric and rectosigmoid cancer
    1985 ►
  84. Kolarić K; Potrebica V; Stanovnik M
    Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil vs. 5-fluorouracil alone in metastatic gastric and rectosygmoid cancer
    1985 ►
  85. Kolarić K; Roth A; Potrebica V; Stanovnik S
    4-epi-doxorubicin + 5-fluorouracil vs 5-fuorouracil alone in advanced gastric cancer - preliminary report of a phase III controlled clinical trial
    1984 ►
  86. Naglas M; Kmetec A
    RANDOMIZED PROSPECTIVE TRIAL COMPARING TWO TREATMENT SCHEDULES OF 5-FLUOROURACIL, METHYL-CCNU, AND VINCRISTINE IN ADVANCED COLORECTAL CANCER
    1980 ►
  87. Pirc B; Naglas M; Červek J; Kmetec A
    KLINIčNI PREIZKUS - SEMUSTIN - NAPREDOVALI RAK KOLONA. (RANDOMIZIRAN PERSPEKTIVNI POSKUS PRIMERJANJA DVEH SHEM ZDRAVLJENJA S 5-FLUOROURACILOM, METHYL-CCNU IN VINKRISTINOM PRI NAPREDOVALNEM RAKU ŠIROKEGA čREVESA IN DANKE)
    1978 ►
  88. Čufer T
    Adjuvant therapy of breast cancer: update
    1999 ►
  89. Štabuc B; Markovič A; Plesničar A; Cizelj TE
    Double modulation of 5-fluorouracil by leucovorin and low-dose methotrexate in advanced colorectal cancer
    2000 ►
  90. Bonnefoi H; Biganzoli L; Čufer T; Hamilton A; Mauriac L; Van Hoorebeeck I; Piccart M
    A feasibility study of epirubicin (E) in combination with cyclophosphamide (C) and infusional 5-fluorouracil (F-infu)(CEF-infu) as primary treatment of large operable (LO) or locally advanced/inflammatory (LA/I) breast cancer (BC)
    1999 ►
  91. Štabuc B
    Chemotherapy of gastrointestinal tumors
    1997 ►
  92. Therasse P; Mauriac L; Welnicka M; Bruning P; Čufer T; Tomiak E; Curran D; Ramirez A; Koopmanschap M; Piccart M
    An EORTC-NCIC-SAKK neoadjuvant randomized phase III study comparing CEF (5FU, epirubicin, cyclophosphamide) vs dose intensified EC+G-CSF (filgrastim) in locally advanced breast cancer (LABC): updated results including quality of life
    1998 ►
  93. Pušnik Dušan
    Trabekulektomija, 5 fluorouracil filtracijska operacija - pol leta izkušenj
    1997 ►
  94. Colleoni M; Price K; Gelber RD; Castiglione-Gertsch M; Rudenstam CM; Coates A; Thuerlimann B; Lindtner J; Collins J; Goldhirsch A
    Dose-response effect of adjuvant cyclophosphamide, methotrexate, fluorouracil in node-positive breast cancer
    1998 ►
  95. Pušnik Dušan
    Trabekulektomija, 5 fluorouracil filtracijska operacija - pol leta izkušenj
    [Trabeculectomia, 5 fluorouracil filtering surgery - 1/2 year follow up]
    1997 ►
  96. Štabuc Borut; Markovič Aleksandra; Brecelj Erik; Bešlija Samir; Cizej Tomaž-Edvard
    Phase II study of fluorouracil, leucovorin and interferon alpha-2a in patients with advanced colon cancer
    [Zdravljenje bolnikov z metastatskim rakom širokega črevesa s fluorouracilom, levkovorinom in interferonom alfa-2a]
    1998 ►
  97. Pendas S; Jaroszeski MJ; Gilbert R; Hyacinthe M; Dang V; Hickey J; Pottinger C; Illingworth P; Heller R
    Direct delivery of chemotherapeutic agents for the treatment of hepatomas and sarcomas in rat models
    [Neposredni vnos kemoterapevtov v celice kot način zdravljenja hepatomov in sarkomov na podganah]
    1998 ►
  98. Grabenbauer Gerhard G; Panzer M; Hueltenschmidt B; Doeker R; Huber K; Kuhne-Velte H J; Hutter M; Ruehl U; Budach V; Wendt T G; et al ;
    Combined radiation and chemotherapy for squamous cell carcinoma of the anal canal: results and prognostic variables in a multiinstitutional series of 173 patients
    1997 ►
  99. Crispino Sergio; Ghezzi P; Ribecco A; Ponticelli P; Lastrucci L; Colombo A; Ardizzoia A; Parmigiani F; Krengli M; Gambaro G; Taino R; Simeone F
    Concomitant radio-chemotherapy for larynx preservation
    1997 ►
  100. Štabuc B
    Sistemsko zdravljenje črevesnega raka
    1996 ►

1 101  

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko